Tirilazad
| Tirilazad | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Tirilazad is a synthetic steroid derivative that acts as a potent inhibitor of lipid peroxidation. It is primarily investigated for its neuroprotective properties in the treatment of acute neurological injuries such as subarachnoid hemorrhage and spinal cord injury.
Mechanism of Action[edit]
Tirilazad functions by inhibiting the peroxidation of lipids in cell membranes, a process that can lead to cell damage and death. This is particularly important in the context of central nervous system injuries, where oxidative stress plays a significant role in secondary injury mechanisms. By reducing lipid peroxidation, Tirilazad helps to preserve cellular integrity and function.
Clinical Applications[edit]
Tirilazad has been studied in various clinical settings, particularly in the management of subarachnoid hemorrhage and spinal cord injury. In these conditions, the drug is thought to mitigate the effects of oxidative stress and inflammation, potentially improving neurological outcomes.
Subarachnoid Hemorrhage[edit]
In patients with subarachnoid hemorrhage, Tirilazad has been evaluated for its ability to reduce the incidence of vasospasm, a common and serious complication. While early studies showed promise, subsequent trials have yielded mixed results, and its use in this context remains controversial.
Spinal Cord Injury[edit]
Tirilazad has also been investigated for its potential to improve outcomes following spinal cord injury. The drug's ability to limit oxidative damage and inflammation is thought to contribute to neuroprotection and functional recovery.
Pharmacokinetics[edit]
Tirilazad is administered intravenously, and its pharmacokinetic profile is characterized by rapid distribution and metabolism. The drug is metabolized primarily in the liver and excreted in the urine. Its half-life and clearance rates can vary depending on the patient's condition and other factors.
Side Effects[edit]
The use of Tirilazad can be associated with several side effects, including gastrointestinal disturbances, hypotension, and allergic reactions. Careful monitoring is required to manage these potential adverse effects.
Research and Development[edit]
Despite initial enthusiasm, the development of Tirilazad has faced challenges due to inconsistent clinical trial results. Research continues to explore its potential benefits and limitations in various neurological conditions.
Related pages[edit]
-
Tirilazad
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian